PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
The review concerns on the testing of platelet function in Chd patients receiving antiplatelet medications. the results are shown of the main large-scale studies demonstrating the relationship of the residual platelet activity level with the development of ishemic and hemorrhagic complications. the...
Saved in:
Main Authors: | A. L. Komarov, E. P. Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2015-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/225 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RESIDUAL PLATELET REACTIVITY TO ADP AND THE RISK OF BLEEDING IN STABLE CHD PATIENTS RECEIVING DOUBLE ANTIPLATELET THERAPY FOR ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: E. V. Guskova, et al.
Published: (2015-03-01) -
ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01) -
THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01) -
Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period
by: T. P. Pronko, et al.
Published: (2025-01-01) -
Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1
by: A. L. Komarov, et al.
Published: (2021-07-01)